GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medfield Diagnostics AB (XSAT:MEDF) » Definitions » Debt-to-Equity

Medfield Diagnostics AB (XSAT:MEDF) Debt-to-Equity : 0.00 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Medfield Diagnostics AB Debt-to-Equity?

Medfield Diagnostics AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. Medfield Diagnostics AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. Medfield Diagnostics AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr69.67 Mil. Medfield Diagnostics AB's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Medfield Diagnostics AB's Debt-to-Equity or its related term are showing as below:

During the past 13 years, the highest Debt-to-Equity Ratio of Medfield Diagnostics AB was 0.03. The lowest was 0.00. And the median was 0.00.

XSAT:MEDF's Debt-to-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.22
* Ranked among companies with meaningful Debt-to-Equity only.

Medfield Diagnostics AB Debt-to-Equity Historical Data

The historical data trend for Medfield Diagnostics AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medfield Diagnostics AB Debt-to-Equity Chart

Medfield Diagnostics AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medfield Diagnostics AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medfield Diagnostics AB's Debt-to-Equity

For the Medical Devices subindustry, Medfield Diagnostics AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medfield Diagnostics AB's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medfield Diagnostics AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Medfield Diagnostics AB's Debt-to-Equity falls into.



Medfield Diagnostics AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Medfield Diagnostics AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Medfield Diagnostics AB's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medfield Diagnostics AB  (XSAT:MEDF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Medfield Diagnostics AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Medfield Diagnostics AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Medfield Diagnostics AB Business Description

Traded in Other Exchanges
N/A
Address
Medicinaregatan 8B, Gothenburg, SWE, 413 90
Medfield Diagnostics AB develops, markets and sells diagnostic instrumentation based on microwave technology. The company researches the use of microwave technology in stroke diagnostics. Its products consist of Strokefinder and Impending Applications.

Medfield Diagnostics AB Headlines

No Headlines